Related Experiment Video

Updated: Aug 9, 2026

Generation of Organotypic Raft Cultures from Primary Human Keratinocytes
07:26

Generation of Organotypic Raft Cultures from Primary Human Keratinocytes

Published on: February 22, 2012

A protease inhibitor specifically inhibits growth of HPV-infected keratinocytes

David A Drubin1, Margaret E McLaughlin-Drubin, Gary A Clawson

  • 1The Jake Gittlen Cancer Research Institute, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|March 28, 2006
PubMed

Insights

Protease inhibitors show anticancer effects against human papillomavirus (HPV) in cervical cancer models. Unexpectedly, the therapeutic benefit is independent of targeting nuclear chymotrypsin-like protease activity (NCLPA).

Area of Science:

  • Oncology
  • Virology
  • Biochemistry

Background:

  • Protease inhibitors possess known anticancer properties, but their specific targets and mechanisms are unclear.
  • Human papillomavirus (HPV) is a key cause of cervical cancer.
  • Nuclear chymotrypsin-like protease activity (NCLPA) is implicated in cellular transformation.

Purpose of the Study:

  • To investigate the role of NCLPA in HPV-infected keratinocytes.
  • To evaluate the efficacy of a protease inhibitor targeting NCLPA in HPV-associated cervical dysplasia models.
  • To explore the mechanism of protease inhibitor action in HPV-infected cells.

Main Methods:

  • Assessed NCLPA levels in keratinocytes infected with high-risk HPV types.
  • Utilized organotypic raft cultures of HPV-infected keratinocytes.
  • Administered a chloromethyl ketone protease inhibitor selective for NCLPA.

Main Results:

  • NCLPA was significantly elevated in keratinocytes infected with high-risk HPV.
  • The protease inhibitor demonstrated specific growth inhibition of high-risk HPV-infected cells in raft cultures.
  • The observed HPV-dependent growth inhibition was independent of changes in NCLPA levels.

Conclusions:

  • Elevated NCLPA is associated with high-risk HPV infection.
  • Protease inhibitors can inhibit the growth of HPV-infected cervical cells.
  • Therapeutic strategies targeting HPV-infected cells may be effective independently of NCLPA modulation.

More Related Videos

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Related Concept Videos

Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...